Compare Novo Nordisk A/S (NVO) vs Old Dominion Freight Line Inc (ODFL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Old Dominion Freight Line Inc — how do they compare? Novo Nordisk A/S trades at $45.96 (market cap $207.85B), while Old Dominion Freight Line Inc trades at $209.64 (market cap $43.43B). The key difference: Novo Nordisk A/S is far larger — about 4.8× Old Dominion Freight Line Inc's market cap, and Novo Nordisk A/S pays the higher dividend (3.81%). Which is the better fit depends on your goals.
| NVO | ODFL | |
|---|---|---|
Market Cap | $207.85B | $43.43B |
Sector | Health | Industrials |
52-Week High | $63.98 | $248.73 |
52-Week Low | $35.29 | $126.29 |
Enterprise Value | $222.55B | $43.17B |
Dividend Yield | 3.81% | 0.55% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Old Dominion Freight Line Inc
Old Dominion Freight Line is the fourth-largest less-than-truckload carrier in the United States, with more than 240 service centers and 9,200-plus tractors. OD is by far one of the most disciplined and efficient providers in the trucking industry, and its profitability and capital returns stand head and shoulders above its peers. Strategic initiatives revolve around increasing network density through market share gains and maintaining industry-leading service via consistent infrastructure investment.
Read more on ODFL →
